Yueyun Liu Selected Research

Metabolic Syndrome (Dysmetabolic Syndrome X)

1/2019

Involvement of Hepatic SHIP2 and PI3K/Akt Signalling in the Regulation of Plasma Insulin by Xiaoyaosan in Chronic Immobilization-Stressed Rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yueyun Liu Research Topics

Disease

6	Body Weight (Weight, Body) 01/2020 - 05/2018
3	Mental Disorders (Mental Disorder) 01/2024 - 01/2019
1	Neuroinflammatory Diseases 01/2024
1	Fatigue 01/2023
1	Chronic Fatigue Syndrome (Myalgic Encephalomyelitis) 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2022
1	Premenstrual Dysphoric Disorder 04/2020
1	Liver Neoplasms (Liver Cancer) 04/2020
1	Psychotic Disorders (Schizoaffective Disorder) 01/2020
1	Diabetes Mellitus 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Anorexia 01/2019
1	Depressive Disorder (Melancholia) 05/2018

Drug/Important Bio-Agent (IBA)

5	xiaoyaosanIBA 04/2020 - 05/2018
5	Sucrose (Saccharose)IBA 01/2020 - 05/2018
3	Fluoxetine (Prozac)FDA LinkGeneric 01/2020 - 05/2018
1	Biomarkers (Surrogate Marker)IBA 01/2024
1	Monoamine Oxidase (MAO)IBA 01/2024
1	Mannose (D-Mannose)IBA 01/2023
1	Taurine FDA Link 01/2023
1	ginsenoside Rg1IBA 01/2023
1	Linoleic Acid (Linoleate)IBA 01/2022
1	Trastuzumab (Herceptin)FDA Link 01/2022
1	Phospholipases (Phospholipase)IBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 01/2022
1	pyrimidineIBA 01/2022
1	hydroxysafflor yellow AIBA 04/2020
1	Beclin-1IBA 04/2020
1	OrexinsIBA 01/2020
1	A-factor (Streptomyces)IBA 01/2019
1	Complement System Proteins (Complement)IBA 01/2019
1	Antidepressive Agents (Antidepressants)IBA 01/2019
1	Tryptophan (L-Tryptophan)FDA Link 01/2019
1	ApelinIBA 05/2018